Join us.


AI Scientist Intern · London

With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.


The Role

We are seeking research scientists and engineers at all levels of experience to join our team in London to work closely with AI scientists, engineers, informaticians, and drug scientists. As part of your internship, you will apply your machine learning knowledge and engineering rigour to develop and execute a research project around the core problems we work on at BenevolentAI: using machine learning to advance drug discovery.

Primary Responsibilities

We have one role available in each of the following three product areas:
  • As part of the Knowledge product area, you will work on state-of-the-art NLP methods for Named Entity Recognition, Entity Linking and Relation Extraction. You will help us improve (1) our in-house methods for automatic information extraction from biomedical literature and patents, and (2) the way we represent this knowledge so it’s most useful for Bioinformaticians and Drug Discoverers.
  • As part of the Precision Medicine product area, you will work on the development and evaluation of methods to identify clinically-relevant patient subgroups leading to actionable insights. You will help us improve how we identify and associate genetic variants with disease subtypes using state-of-the-art machine learning models on genomic data. 
  • As part of the Chemistry product area, you will contribute to the development and evaluation of machine learning methods for analysis and prediction of chemical properties in the limited data setting. With an emphasis on maximising impact on live drug discovery programmes, you will help us build on the state-of-the-art in the fields of generative and predictive modelling.
  • Pursue a research project to investigate new approaches in applying tech-driven methods for drug discovery and development.
  • Work as a member of a cross-functional team comprising specialists in informatics, engineering, AI, drug discovery and product for applied research.

We are looking for someone with

  • A strong academic background, showcasing creativity and persistence in efforts
  • A BSc/BEng (MSc/MEng/DPhil preferred) in machine learning, computer science, or a related field, or equivalent commercial experience
  • Experience using tools such as Pandas, Scikit-learn, Tensorflow, PyTorch, etc.
  • Strong programming skills
  • Awareness of, and passion for, the state of the art in machine learning
  • Nice to have: experience applying modern ML and AI techniques to biomedical data, molecular data, or clinical data -- for example, genomics, transcriptomics, epigenomics, proteomics, chemistry data, or biomedical scientific literature


Applications close on February 12th, 2021. In addition to your CV, please send us a cover letter.

Terms and Conditions

Salary: We offer remuneration for the duration of the internships. However, remuneration remains subject to the University regulations & T&C’s - should they not comply with our policy, we reserve the right to review the salary allowance.

We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey.  If that sounds like a fit for you, hit the apply button and join us.

About us

BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.

Want to do a little more research before you apply?

Head over to our Glassdoor page to learn about our benefits, culture and to find out what our team thinks about life at Benevolent. You can also find out more about us on LinkedIn and Twitter.

Important Note

Our team will only contact you from the domain If you receive a suspicious contact request, please email Thank you.